Sacral neuromodulation for urinary incontinence
Sacral neuromodulation (SNM) was first approved in Europe in 1994 and the United States in 1997. Since its initial approval, indications for SNM have expanded to include urinary urgency/frequency, urgency urinary incontinence (UUI), non-obstructive urinary retention, and fecal incontinence. In the r...
Saved in:
| Main Authors: | Tyler Trump, Howard B. Goldman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Continence |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772973724006301 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcomes of Sacral Neuromodulation and Intradetrusor Onabotulinum Toxin in the Management of Stroke Associated Urinary Incontinence
by: Tyler Trump, et al.
Published: (2025-03-01) -
Global insights into overactive bladder management: A survey of physician preferences and practices
by: Omer Anis, et al.
Published: (2025-09-01) -
Sacral neuromodulation for faecal incontinence
by: K.E. Matzel, et al.
Published: (2024-12-01) -
Sacral neuromodulation update in 2024: Insights from the ICS workshop 2023
by: Emre Huri, et al.
Published: (2024-12-01) -
Minimally invasive therapies for older patients with urgency urinary incontinence: Current evidence and recommendations
by: Jacqueline Zillioux, et al.
Published: (2025-03-01)